The Impact of Icodextrin on Mortality of Peritoneal Dialysis Patients
Keywords:
-
Abstract
-
Downloads
Download data is not yet available.
References
1 Ha H, Yu MR, Choi HN, et al. Effects of Conventional and New Peritoneal Dialysis Solutions on Human Peritoneal Mesothelial Cell Viability and Proliferation. Perit Dial Int 2000;20(5):S10–8. Doi: https://doi.org/10.1177/089686080002005S03.
2 Han NM, Prasad N, Meyyappa J, et al. WCN25-4136 Outcomes of CAPD Patients Between Icodextrin and Non-Icodextrin Peritoneal Dialysis Fluid Usages. Kidney Int Reports 2025;10(2):S723. Doi: https://doi.org/10.1016/j.ekir.2024.11.1283.
3 Li PKT, Culleton BF, Ariza A, et al. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 2013;24(11):1889–900. Doi: 10.1681/ASN.2012100987.
4 Davies SJ, Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12(5):1046–51. Doi: 10.1681/ASN.V1251046.
5 Li Y, Yang C, Zhou Z. Clinical benefits of icodextrin in peritoneal dialysis: Evidence from a multicenter, prospective, randomized controlled trial. J Int Med Res 2025;53(9):1–12. Doi: https://doi.org/10.1177/03000605251379205.
6 Budiman MF, Afiatin A, Andhika R. Differences in Type Characteristics of Peritoneal Membrane Using Peritoneal Equilibrium Test In End Stage Renal Failure Patients Undergoing Peritoneal Dialysis at Hasan Sadikin Hospital, Bandung. Indones J Kidney Hypertens 2025;2(3):101–7. Doi: doi:10.32867/inakidney.v2i3.192.
7 Wiggins KJ, McDonald SP, Brown FG, et al. High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant 2007;22(10):3005–12. Doi: doi:10.1093/ndt/gfm324.
8 Wang I-K, Chan CI, Lin AH-F, et al. The impact of icodextrin on the outcomes of incident peritoneal dialysis patients. PLoS One 2024;19(3):1–12. Doi: 10.1371/journal.pone.0297688.
9 Kanno A, Tsujimoto Y, Fujii T, et al. Comparison of clinical effects between icodextrin and glucose solutions on outcomes of peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials. Ren Replace Ther 2020;6(7):1–11. Doi: https://doi.org/10.1186/s41100-019-0253-4.
10 Goossen K, Becker M, Marshall MR, et al. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Kidney Dis 2020;75(6):830–46. Doi: 10.1053/j.ajkd.2019.10.004.
11 Davies S, Zhao J, McCullough KP, et al. International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival. Kidney360 2022;3:872–82. Doi: doi: https://doi.org/10.34067/KID.0006922021.
12 Han SH, Ahn SV, Yun JY, et al. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2011;27:2044–50. Doi: doi: 10.1093/ndt/gfr580.
13 Yang J-Y, Chen L, Peng Y-S, et al. Icodextrin Is Associated with a Lower Mortality Rate in Peritoneal Dialysis Patients. Perit Dial Int 2019;39(3):252–60. Doi: doi: 10.3747/pdi.2018.00217.
14 Ng JK-C, Kwan BC-H, Chow K-M, et al. Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients. PLoS One 2018:1–11. Doi: https://doi.org/10.1371/journal.pone.0202203.
15 Biesen W Van, Verger C, Heaf J, et al. Evolution Over Time of Volume Status and PD-Related Practice Patterns in an Incident Peritoneal Dialysis Cohort. Clin J Am Soc Nephrol 2019;14:882–93. Doi: doi: 10.2215/CJN.11590918.
2 Han NM, Prasad N, Meyyappa J, et al. WCN25-4136 Outcomes of CAPD Patients Between Icodextrin and Non-Icodextrin Peritoneal Dialysis Fluid Usages. Kidney Int Reports 2025;10(2):S723. Doi: https://doi.org/10.1016/j.ekir.2024.11.1283.
3 Li PKT, Culleton BF, Ariza A, et al. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 2013;24(11):1889–900. Doi: 10.1681/ASN.2012100987.
4 Davies SJ, Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12(5):1046–51. Doi: 10.1681/ASN.V1251046.
5 Li Y, Yang C, Zhou Z. Clinical benefits of icodextrin in peritoneal dialysis: Evidence from a multicenter, prospective, randomized controlled trial. J Int Med Res 2025;53(9):1–12. Doi: https://doi.org/10.1177/03000605251379205.
6 Budiman MF, Afiatin A, Andhika R. Differences in Type Characteristics of Peritoneal Membrane Using Peritoneal Equilibrium Test In End Stage Renal Failure Patients Undergoing Peritoneal Dialysis at Hasan Sadikin Hospital, Bandung. Indones J Kidney Hypertens 2025;2(3):101–7. Doi: doi:10.32867/inakidney.v2i3.192.
7 Wiggins KJ, McDonald SP, Brown FG, et al. High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant 2007;22(10):3005–12. Doi: doi:10.1093/ndt/gfm324.
8 Wang I-K, Chan CI, Lin AH-F, et al. The impact of icodextrin on the outcomes of incident peritoneal dialysis patients. PLoS One 2024;19(3):1–12. Doi: 10.1371/journal.pone.0297688.
9 Kanno A, Tsujimoto Y, Fujii T, et al. Comparison of clinical effects between icodextrin and glucose solutions on outcomes of peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials. Ren Replace Ther 2020;6(7):1–11. Doi: https://doi.org/10.1186/s41100-019-0253-4.
10 Goossen K, Becker M, Marshall MR, et al. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Kidney Dis 2020;75(6):830–46. Doi: 10.1053/j.ajkd.2019.10.004.
11 Davies S, Zhao J, McCullough KP, et al. International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival. Kidney360 2022;3:872–82. Doi: doi: https://doi.org/10.34067/KID.0006922021.
12 Han SH, Ahn SV, Yun JY, et al. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2011;27:2044–50. Doi: doi: 10.1093/ndt/gfr580.
13 Yang J-Y, Chen L, Peng Y-S, et al. Icodextrin Is Associated with a Lower Mortality Rate in Peritoneal Dialysis Patients. Perit Dial Int 2019;39(3):252–60. Doi: doi: 10.3747/pdi.2018.00217.
14 Ng JK-C, Kwan BC-H, Chow K-M, et al. Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients. PLoS One 2018:1–11. Doi: https://doi.org/10.1371/journal.pone.0202203.
15 Biesen W Van, Verger C, Heaf J, et al. Evolution Over Time of Volume Status and PD-Related Practice Patterns in an Incident Peritoneal Dialysis Cohort. Clin J Am Soc Nephrol 2019;14:882–93. Doi: doi: 10.2215/CJN.11590918.
Published
2025-12-24
How to Cite
1.
Samsu N. The Impact of Icodextrin on Mortality of Peritoneal Dialysis Patients. inakidney [Internet]. 24Dec.2025 [cited 5Mar.2026];2(3):98-00. Available from: https://inakidneyhypertension.co.id/index.php/inakidney/article/view/225
Section
Editorial
Copyright (c) 2025 Indonesian Journal of Kidney and Hypertension
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:
- Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.
1.png){kind=logo}
